Hybrid Conferencee

International Conference on Gastrointestinal Cancer Research (ICGCR - 26)

15th - 16th October 2026 | Prague, Czech Republic

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Prague. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Prague event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Prague conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Prague, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Prague."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Tumor Biology

This session will explore the latest discoveries in the molecular mechanisms underlying gastrointestinal tumors. Emphasis will be placed on the interplay between genetic and environmental factors in tumor development.

Track 02

Innovations in Cancer Diagnostics

This track will focus on novel diagnostic techniques and biomarkers for early detection of gastrointestinal cancers. Participants will discuss the implications of these advancements for improving patient outcomes.

Track 03

Therapeutic Approaches in GI Oncology

This session will cover emerging therapeutic strategies, including targeted therapies and immunotherapy, for the treatment of gastrointestinal cancers. The discussion will highlight recent clinical trial results and their potential impact on clinical practice.

Track 04

Clinical Trials in Gastrointestinal Cancer

This track will present findings from recent clinical trials aimed at evaluating new treatments for gastrointestinal malignancies. Attendees will gain insights into trial design, patient selection, and outcome measures.

Track 05

Molecular Pathology of GI Cancers

This session will delve into the role of molecular pathology in understanding gastrointestinal cancers. Topics will include the significance of genetic mutations and epigenetic changes in tumor progression.

Track 06

Translational Research in GI Oncology

This track will highlight the translation of laboratory findings into clinical applications for gastrointestinal cancer treatment. Participants will discuss successful case studies and ongoing research efforts.

Track 07

Cancer Prevention Strategies

This session will focus on effective strategies for the prevention of gastrointestinal cancers, including lifestyle modifications and screening programs. The importance of public health initiatives in reducing cancer incidence will be emphasized.

Track 08

Treatment Outcomes and Quality of Life

This track will examine the impact of various treatment modalities on patient outcomes and quality of life in gastrointestinal cancer patients. Discussions will include survivorship issues and long-term follow-up care.

Track 09

Emerging Biomarkers in GI Cancer

This session will explore the identification and validation of emerging biomarkers for gastrointestinal cancers. The potential of these biomarkers for personalized medicine and targeted therapies will be discussed.

Track 10

Multidisciplinary Approaches to GI Cancer Care

This track will emphasize the importance of a multidisciplinary approach in the management of gastrointestinal cancers. Collaboration among oncologists, surgeons, radiologists, and pathologists will be highlighted.

Track 11

Health Disparities in Gastrointestinal Cancer

This session will address the disparities in incidence, treatment, and outcomes of gastrointestinal cancers across different populations. Strategies to mitigate these disparities through research and policy will be discussed.